Analysis of the cost-effectiveness of liquid biopsy to determine treatment change in patients with her2-positive advanced breast cancer in Colombia

"Background: Breast cancer is highly prevalent worldwide and leads to high health-care costs. HER2-positive subtype represents 30% of all breast cancers and is associated with a poor prognosis. Patients treated with anti-HER2 therapies frequently develop resistance and require pharmacological t...

Descripción completa

Detalles Bibliográficos
Autores Principales: Sánchez-Calderón, Diana, Pedraza, Adriana, Mancera Urrego, Catalina, Mejía-Mejía, Aurelio, Montealegre-Páez, Ana Lorena, Perdomo, Sandra
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Dove Medical Press Ltd 2020
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/23699
https://doi.org/10.2147/CEOR.S220726